| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An industrial perspective on positive allosteric modulation as a means to discover safe and selective drugs
|
Rocheville, Magalie
|
|
2010
|
7 |
1 |
p. e87-e94
nvt p.
|
artikel
|
| 2 |
Cell-based assays for kinase drug discovery
|
Smith, Gary K.
|
|
2010
|
7 |
1 |
p. e13-e19
nvt p.
|
artikel
|
| 3 |
Epigenetic control of the immune system: histone demethylation as a target for drug discovery
|
Lora, Jose M.
|
|
2010
|
7 |
1 |
p. e67-e75
nvt p.
|
artikel
|
| 4 |
Epigenetics: tools and technologies
|
Janzen, William P.
|
|
2010
|
7 |
1 |
p. e59-e65
nvt p.
|
artikel
|
| 5 |
G protein-coupled receptor kinases: Specific phosphorylation of 7TM receptors and beyond
|
Murga, C.
|
|
2010
|
7 |
1 |
p. e43-e49
nvt p.
|
artikel
|
| 6 |
Image-based high-content reporter assays: limitations and advantages
|
Gasparri, Fabio
|
|
2010
|
7 |
1 |
p. e21-e30
nvt p.
|
artikel
|
| 7 |
Label-free receptor assays
|
Fang, Ye
|
|
2010
|
7 |
1 |
p. e5-e11
nvt p.
|
artikel
|
| 8 |
Mechanistic pharmacology, new developments
|
Wise, Alan
|
|
2010
|
7 |
1 |
p. e1-e3
nvt p.
|
artikel
|
| 9 |
Seeking ligand bias: assessing GPCR coupling to β-arrestins for drug discovery
|
Bohn, Laura M.
|
|
2010
|
7 |
1 |
p. e37-e42
nvt p.
|
artikel
|
| 10 |
Uncovering GPCR heteromer-biased ligands
|
Mustafa, Sanam
|
|
2010
|
7 |
1 |
p. e77-e85
nvt p.
|
artikel
|
| 11 |
Use of functional assays to detect and quantify functional selectivity
|
Clarke, William P.
|
|
2010
|
7 |
1 |
p. e31-e36
nvt p.
|
artikel
|
| 12 |
Use of small RNAs for therapeutic gene silencing: risk versus benefit
|
Börner, Kathleen
|
|
2010
|
7 |
1 |
p. e51-e57
nvt p.
|
artikel
|
Tijdschrift beschrijving